openPR Logo
Press release

Active Pharmaceutical Ingredient Market to grow significantly witnessing a CAGR

09-22-2022 03:44 PM CET | Health & Medicine

Press release from: Persistence Market Research

Active Pharmaceutical Ingredient Market to grow significantly

Active pharmaceutical ingredients are drugs used for chronic diseases such as neuropathic pain, pulmonary diseases, cancer, diabetes, and heart diseases. However, these ingredients have both, benefits as well as adverse effects.

Pharma companies have focused on modernizing their manufacturing methods to improve overall product quality. This also means automation in process development, something that was previously done manually. Installing equipment with large capacities in terms of volume also enables greater production yield.

According to the revised report published by Persistence Market Research, the global active pharmaceutical ingredient market valued at around US$ 180 Bn in 2020, and is predicted to expand at a CAGR of more than 4% over the forecast period (2021-2031).

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/11260

Company profiles:
• Pfizer Inc.
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• Cipla Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline plc
• Hepalink Group
• Lonza
• Merck & Co. Inc.
• Sandoz International GmbH
• Aurobindo Pharma Limited
• Fresenius Kabi LLC

Request for Methodology @ https://www.persistencemarketresearch.com/methodology/11260

Key Takeaways from Market Study
• Small molecule active pharmaceutical ingredients are expected to contribute more than 91% revenue share in the market by 2031, owing to their wide availability and potency to relieve moderate to severe pain, usually after a surgery or traumatic injury.

• Non-controlled substances are expected to account for more than half of the global market share.

• Among all the end users, pharmaceutical companies accounted for more market share than others.

• East Asia holds the highest share in the global active pharmaceutical ingredient market, owing to the presence of more CMOs, high healthcare expenditure, and growing research & development efforts in the region.

• Key players are focused on strengthening their clinical pipelines with new discoveries of novel abuse-deterrent formulations.

• The market in the India is projected expand at a CAGR around 4% through 2021-2031. The U.S. holds a big portion of global revenue, and accounts for more than 87% share in the North America market.

"Strong growth in demand is being witnessed for small molecules, owing to their potency, efficacy, and safety," says an analyst of Persistence Market Research.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/11260

Increasing Healthcare Spending on Active Pharmaceutical Ingredients
Global healthcare spending increased at a CAGR of 6.92% from 2003 to 2013. This growth in healthcare spending significantly outpaced the growth rate of population in this period, which grew at a CAGR of 1.22%. Consequently, per capita healthcare spending increased from US$ 597 in 2003 to US$ 1,032 in 2013, increasing at a CAGR of 5.62%.

Rise in healthcare spending across all regions has increased access to quality healthcare, and is expected to continue to drive demand for pharmaceutical products.

• On 25 March 2019, TUL secured its position in the 2018 China TOP 10 Member Enterprises of APIs. The position was awarded to TUL for its excellent exporting and importing profile of API, pharmaceutical formulations, and Chinese medicines in 2018.

• In 2016, Novartis' Sandoz discontinued operations at its Maharashtra, India site, as part of global plans to optimize manufacturing. The site, located in west-central India, employed 170 people and manufactured antibiotics and APIs.

What Does the Report Cover?
Persistence Market Research offers a unique perspective and actionable insights on the active pharmaceutical ingredient market in its latest study, presenting historical demand assessment of 2016 - 2020 and projections for 2021 - 2031. The research study is based on API (small molecules, peptides & oligonucleotides, carbohydrate drugs, and steroidal drugs) and end user (contract manufacturing organizations (CMOs), pharmaceutical companies, contract development manufacturing organizations (CDMOs), and compounding pharmacies), across seven key regions of the world.

Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Active Pharmaceutical Ingredient Market to grow significantly witnessing a CAGR here

News-ID: 2746296 • Views: 126

More Releases from Persistence Market Research

North America To Account For Around 42.5% Global Thermostatic Mixing Valves Mark …
The global thermostatic mixing valves market is anticipated to witness a growth rate of around 4.8% from 2022 to 2032. Market growth is anticipated to be driven by rise in urbanization, growing construction sector, and increasing demand for smart plumbing solutions. High use of thermostatic mixing valves in the residential sector has been prominently driving market growth over the past few years. However, demand is expected to increase further due
Open process automation to be in great demand in the Oil & Gas Data Monetization …
As per a study by Persistence Market Research, from US$ 40.3 billion in 2022 to US$ 161.6 billion in 2032, the global Oil and Gas Data Monetization Market is predicted to grow at a 14.9% CAGR from 2022 to 2032. The implementation of Industry 4.0 has paved the road to a new era of competitiveness which further is driving the demand for oil and gas data monetization market. This implementation is
Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market …
According to the latest market report published by Persistence Market Research, titled 'Global Surgical Hemostats, Internal Tissue Sealants and Adhesion Barriers Market: Industry Analysis and Forecast (2017-2025)', the global surgical hemostats, internal tissue sealants and adhesion barriers market is expected to expand at a CAGR of 8.9% during the forecast period 2017-2025, crossing a value beyond US$ 6.2 Bn by 2025 end. The market is classified based on product type, application,
Architectural LED Products Market Unit Sales to Witness Significant Growth in th …
LED products are comparatively more environment-friendly than other lighting solutions. This benefit has positively impacted market growth over the past years. LED products are energy-efficient, which helps reduce the load on electricity power plants. Besides, LED lights have focused light that helps reduce unwanted light pollution in the environment, which is otherwise caused due to scattered light from other traditional lighting products. LED products also emit negligible heat, as they have

All 5 Releases


More Releases for Pharma

Global Deferasirox Market 2018 - Novartis, Cipla, Sun Pharma, Natco Pharma
Apex Market Reports, recently published a detailed market research study focused on the “Deferasirox Market” across the global, regional and country level. The report provides 360° analysis of “Deferasirox Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Deferasirox on the basis of
Big Pharma Outlook 2026
Boston, MA ReportsWorldwide has announced the addition of a new report title Big Pharma Outlook 2026 to its growing collection of premium market research reports. Pharmavitae Analytics casts its eye out to 2026 with challenging trends in healthcare management set to crystallize, Big Pharma will add $29.5bn in revenues out to 2026, generating $351bn in prescription pharmaceuticals at a low single-digit compound annual growth rate (CAGR) of 0.9%. Using in-house sales forecasts,
Erythrocyte Catalase Market 2017 - Sanofi, Palam Pharma, Bioxera, Zafax Pharma
Apex Research, recently published a detailed market research study focused on the "Erythrocyte Catalase Market" across the global, regional and country level. The report provides 360° analysis of "Erythrocyte Catalase Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Erythrocyte Catalase industry, and estimates the future trend of Erythrocyte Catalase market on
12th World Pharma Congress
Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting in an abundant knowledge of the mechanisms driving drug discovery and development. Pharmaceutical Formulation Market size was USD $147billion in 2015 and is anticipated to reach around USD 175.1 billion by 2018. In USA, the total number of new drugs approved between
12th World Pharma Congress
Conference Series has taken an initiation to conduct International Pharma Congress worldwide. From several years Conference Series has been conducting Pharma Congress conferences in major continents like Europe, America and Asia Pacific. Previous conferences were held in city like USA, with success. Conference Series proudly announces 12th World Pharma Congress for 2017, during October 16-18, at Budapest, Hungary. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage is resulting
4th African Pharma Congress
In the light of this theme, the conference series aims to provide a forum for international researchers from various areas of pharmaceutical sciences like chemical processing, industrial practice, analytical methods and pharmacological actions by providing a platform for critical analysis of new agenda, and to share latest cutting-edge research findings and results about all aspects of Pharmacy We are honoured to invite pharmacists, researchers, professors, scientific communities, delegates, students, business